ABIVAX (EPA:ABVX) | Finanzwire

Basculer en Français

10793	Companies
233169	Keywords
161773	Articles
124381	Press releases

Home
Companies
ABIVAX

BRIEF

published on 07/30/2026 at 22:10, 2 days 10 hours ago

Abivax receives positive feedback from the FDA for obefazimod

FDA Abivax Obefazimod Ulcerative Colitis Marketing Authorization
BRIEF

published on 07/30/2026 at 22:10, 2 days 10 hours ago

Abivax Advances with FDA on Obefazimod for Ulcerative Colitis

Abivax Obefazimod Ulcerative Colitis NDA Submission FDA Interaction
PRESS RELEASE

published on 07/30/2026 at 22:05, 2 days 10 hours ago

Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
Abivax announces positive pre-NDA interaction with FDA for Obefazimod, on track for NDA submission by end of 2026, reinforcing potential in treating ulcerative colitis

FDA Abivax Obefazimod Ulcerative Colitis NDA Submission
BRIEF

published on 07/24/2026 at 09:51, 8 days 22 hours ago

Sofinnova Partners crosses threshold in ABIVAX

Euronext Paris Voting Rights Abivax Threshold Crossing Sofinnova Partners
BRIEF

published on 07/23/2026 at 22:10, 9 days 10 hours ago

Abivax is strengthening its sales team to prepare for the market launch of obefazimod

Abivax Obefazimod Marketing Inflammatory Diseases Strategic Appointments
BRIEF

published on 07/23/2026 at 22:10, 9 days 10 hours ago

Abivax Expands Commercial Team for Potential U.S. Launch

Biotechnology Abivax Obefazimod Commercial Leadership U.S. Market Entry
PRESS RELEASE

published on 07/23/2026 at 22:05, 9 days 10 hours ago

Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
Abivax strengthens commercial capabilities with strategic leadership appointments, preparing for potential U.S. commercialization of obefazimod. Abivax expands Commercial Leadership Team with industry leaders

Abivax Obefazimod Leadership Appointments U.S. Commercialization Commercial Capabilities
BRIEF

published on 07/17/2026 at 18:05, 15 days 14 hours ago

Update of ABIVAX's share capital and voting rights

Share Capital Voting Rights Biotechnology Actions Abivax
BRIEF

published on 07/06/2026 at 22:10, 26 days 10 hours ago

Abivax Completes its $920 Million Public Offering

Biotechnology Actions Funding Abivax Public Offering
BRIEF

published on 07/06/2026 at 22:10, 26 days 10 hours ago

Abivax Secures $920 Million in Public Offering

Biotechnology Abivax Ulcerative Colitis Public Offering American Depositary Shares

Accesswire

Published on 08/01/2026 at 01:20, 1 day 7 hours ago

Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 7 hours ago

Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 8 hours ago

Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/01/2026 at 00:25, 1 day 8 hours ago

BioNxt Solutions Announces Option Grants
Published on 07/31/2026 at 23:20, 1 day 9 hours ago

Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.

View all ACCESSWIRE

EQS Group

Published on 08/02/2026 at 08:15, 25 minutes ago

Holcim signs agreement to divest its business in the Philippines
Published on 08/01/2026 at 16:35, 16 hours 4 minutes ago

HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 1 day 12 hours ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 1 day 13 hours ago

Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 18:55, 1 day 13 hours ago

Holding(s) in Company

Les Echos

Published on 07/31/2026 at 21:00, 1 day 11 hours ago

Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:27, 1 day 13 hours ago

Share retention commitments (Dutreil Agreement)
Published on 07/31/2026 at 19:14, 1 day 13 hours ago

2026 First-Half financial report
Published on 07/31/2026 at 19:13, 1 day 13 hours ago

Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 1 day 14 hours ago

Covivio Hotels - 2026 Half-year financial report

View all LES ECHOS COMFI WIRE